The quantitative detection of fecal Calprotectin can distribute inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS); it can also be used in the diagnosis of spontaneous peritonitis in patients with liver cirrhosis; it can also be an another choice of early diagnosis marker for IBD patients.